Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy

European Radiology

Volumn 22, Issue 11, 2012, Pages 2533-2539

  Kim, Jae Hun ^a   Kim, Chan Kyo ^a   Park, Byung Kwan ^a   Park, Sung Yoon ^a   Huh, Seung Jae ^a   Kim, Bohyun ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Cervical cancer; Concurrent chemoradiotherapy; Dynamic contrast enhanced MRI; Efficacy; MRI

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; IMAGE ANALYSIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

ADULT; AGED; CHEMORADIOTHERAPY; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84870386296     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2504-4     Document Type: Article

References (21)

1. Nam H, Park W, Huh SJ, Bae DS, Kim BG, Lee JH, Lee JW, do Lim H, Han Y, Park HC, Ahn YC (2007) The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 107: 320-325
2. Wagenaar HC, Trimbos JB, Postema S, Anastasopoulou A, van der Geest RJ, Reiber JH, Kenter GG, Peters AA, Pattynama PM (2001) Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol 82: 474-482
3. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247
4. Hayes C, Padhani AR, Leach MO (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15: 154-163
5. Pickles MD, Gibbs P, Lowry M, Turnbull LW (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24: 843-847
6. Harry VN (2010) Novel imaging techniques as response biomarkers in cervical cancer. Gynecol Oncol 116: 253-261
7. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW (2005) Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 91: 1-10
8. Weber MA, Thilmann C, Lichy MP, Gunther M, Delorme S, Zuna I, Bongers A, Schad LR, Debus J, Kauczor HU, Essig M, Schlemmer HP (2004) Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibilityweighted contrast-enhanced perfusion MRI: initial results. Invest Radiol 39: 277-287
9. Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, Brenton JD, Lomas DJ, Sala E (2009) Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 74: 766-773
10. Yuh WT, Mayr NA, Jarjoura D, Wu D, Grecula JC, Lo SS, Edwards SM, Magnotta VA, Sammet S, Zhang H, Montebello JF, Fowler J, Knopp MV, Wang JZ (2009) Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol 44: 343-350
11. Yamashita Y, Baba T, Baba Y, Nishimura R, Ikeda S, Takahashi M, Ohtake H, Okamura H (2000) Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 216: 803-809
12. Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, Buckley DL, Davidson SE, Logue JP, Hunter RD, West CM (2002) Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54: 759-767
13. Hawighorst H, Knapstein PG, Knopp MV,WeikelW, Brix G, Zuna I, Schonberg SO, Essig M, Vaupel P, van Kaick G (1998) Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 58: 3598-3602
14. Semple SI, Harry VN, Parkin DE, Gilbert FJ (2009) A combined pharmacokinetic and radiologic assessment of dynamic contrastenhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 75: 611-617
15. Leach MO, Brindle KM, Evelhoch JL et al (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92: 1599-1610
16. Kim YS, Lim HK, Kim JH, Rhim H, Park BK, Keserci B, Kohler MO, Bae DS, Kim BG, Lee JW, Kim TJ, Sokka S, Lee JH (2011) Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol 46: 639-647
17. Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232
18. Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT (2007) Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 8: 63-74
19. Hawighorst H, Weikel W, Knapstein PG, Knopp MV, Zuna I, Schonberg SO, Vaupel P, van Kaick G (1998) Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 4: 2305-2312
20. Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, Davis CS, Wen BC, Martin DD, Pelsang RE, Buller RE, Oberley LW, Mellenberg DE, Hussey DH (1996) Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 36: 623-633
21. Schlenger K, Hockel M, Mitze M, Schaffer U,Weikel W, Knapstein PG, Lambert A (1995) Tumor vascularity-a novel prognostic factor in advanced cervical carcinoma. Gynecol Oncol 59: 57-66